/ Active, not recruitingPhase 3 评估硫酸亚铁甘氨酸混盐肠溶胶囊对比多糖铁复合物胶囊治疗缺铁性贫血患者的疗效和安全性。
[Translation] To evaluate the efficacy and safety of ferrous sulfate glycine mixed salt enteric-coated capsules versus polysaccharide iron complex capsules in the treatment of patients with iron deficiency anemia.
证实经12 周的治疗后,硫酸亚铁甘氨酸混盐肠溶胶囊(试验药)相对于多糖铁复合物胶囊(对照药)的非劣效性。
[Translation] The non-inferiority of ferrous sulfate glycine mixed salt enteric-coated capsules (test drug) to polysaccharide iron complex capsules (control drug) was demonstrated after 12 weeks of treatment.
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
To evaluate the efficacy and safety of 12 weeks treatment with Ferrous (II) Glycine Sulphate Complex in comparison to Polyferose capsules in Chinese subjects with manifest Iron Deficiency Anemia.
100 Clinical Results associated with Sanol GmbH
0 Patents (Medical) associated with Sanol GmbH
100 Deals associated with Sanol GmbH
100 Translational Medicine associated with Sanol GmbH